Mild Glaucoma
Glaucoma Medications: Improving Adherence Through Preservative-Free Options
This activity is supported by an educational grant from Thea Pharma Inc.
Glaucoma Management: Rising Out of the Darkness and Into the Light With Rho-Kinase Inhibitors
This activity is supported by an educational grant from Alcon Vision, LLC.
Miniject supraciliary drainage device safe, effective for mild to moderate glaucoma
The supraciliary drainage implant Miniject can safely and effectively treat mild to moderate glaucoma as a standalone procedure, according to a study published in the American Journal of Ophthalmology.
Glaucoma detection key to MIGS success
I am a comprehensive ophthalmologist practicing at the Center for Excellence in Eye Care, a subspecialty ophthalmology group in Miami. Given our location, we see a high proportion of minority patients from the Caribbean.
Advanced glaucoma calls for aggressive, personalized care
Early detection and appropriate management allow most patients to stave off progression of glaucoma beyond the mild to moderate stages and preserve vision.
VIDEO: Aerie updates Rhopressa, Rocklatan programs
SAN FRANCISCO — At Glaucoma 360: New Horizons Forum, Thomas A. Mitro, president and chief operating officer of Aerie Pharmaceuticals, updates the company’s progress with Rhopressa (netarsudil ophthalmic solution 0.02%) and Rocklatan (netarsudil 0.02% and latanoprost 0.005% ophthalmic solution), and discusses receiving the Glaucoma Research Foundation’s Catalyst Award.
Kahook, Samuelson debate MIGS procedures with phaco
KOLOA, Hawaii — Excisional goniotomy is just as safe and effective as device procedures for the treatment of mild-to-moderate glaucoma, Malik Y. Kahook, MD, argued at Hawaiian Eye 2020.